Jiangong Niu Selected Research

Non-Receptor Type 13 Protein Tyrosine Phosphatase

12/2009

Genetic polymorphisms in the PTPN13 gene and risk of squamous cell carcinoma of head and neck.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Jiangong Niu Research Topics

Disease

21	Neoplasms (Cancer) 01/2022 - 03/2003
12	Breast Neoplasms (Breast Cancer) 01/2022 - 07/2013
5	Carcinogenesis 02/2013 - 03/2003
4	Squamous Cell Carcinoma of Head and Neck 05/2011 - 12/2009
4	Pancreatic Neoplasms (Pancreatic Cancer) 05/2009 - 03/2003
3	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 01/2020 - 02/2014
3	Cardiotoxicity 01/2018 - 11/2013
2	Hemorrhage 01/2020 - 02/2014
2	Respiratory Insufficiency (Respiratory Failure) 01/2020 - 02/2014
2	Hypertension (High Blood Pressure) 01/2018 - 11/2013
2	Heart Failure 01/2018 - 11/2013
2	Stomach Neoplasms (Stomach Cancer) 10/2009 - 06/2009
2	Neoplasm Metastasis (Metastasis) 05/2009 - 04/2004
2	Inflammation (Inflammations) 04/2004 - 11/2003
1	Dementia (Dementias) 01/2021
1	Carcinoma (Carcinomatosis) 07/2020
1	Postoperative Pain 01/2020
1	Opioid-Related Disorders (Opiate Addiction) 01/2020
1	Malignant Pleural Effusion 01/2018
1	Malignant Mesothelioma 01/2018
1	Colonic Neoplasms (Colon Cancer) 01/2018
1	Myelodysplastic Syndromes (Myelodysplastic Syndrome) 01/2018
1	Acute Myeloid Leukemia (Acute Myelogenous Leukemia) 01/2018
1	Coronary Artery Disease (Coronary Atherosclerosis) 11/2013
1	Melanoma (Melanoma, Malignant) 05/2013
1	Neoplastic Cell Transformation 02/2013
1	Lung Neoplasms (Lung Cancer) 04/2011
1	Oropharyngeal Neoplasms 12/2010
1	Pancreatic Ductal Carcinoma 06/2005
1	Pathologic Processes 09/2004
1	Adenocarcinoma 03/2003
1	Hepatocellular Carcinoma (Hepatoma) 10/2002

Drug/Important Bio-Agent (IBA)

7	NF-kappa B (NF-kB)IBA 05/2009 - 10/2002
4	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 10/2009 - 03/2003
4	Transcription Factors (Transcription Factor)IBA 05/2009 - 10/2002
3	Opioid Analgesics (Opioids)IBA 01/2020 - 10/2019
3	Trastuzumab (Herceptin)FDA Link 01/2018 - 11/2013
2	Hormones (Hormone)IBA 01/2022 - 01/2021
2	Tamoxifen FDA LinkGeneric 01/2022 - 01/2021
2	Biological ProductsIBA 04/2011 - 09/2004
2	CytosineIBA 10/2010 - 06/2010
2	GuanineIBA 10/2010 - 06/2010
2	Adenine FDA LinkGeneric 10/2010 - 06/2010
2	Interleukin-1alpha (Interleukin 1 alpha)IBA 05/2009 - 04/2004
1	Aromatase InhibitorsIBA 01/2021
1	Biological FactorsIBA 07/2020
1	AnthracyclinesIBA 01/2018
1	Type 1 Melanocortin ReceptorIBA 05/2013
1	integrin-linked kinaseIBA 02/2013
1	AgarIBA 02/2013
1	Insulin-Like Growth Factor Binding Protein 5IBA 05/2011
1	Codon (Codons)IBA 12/2010
1	arginylarginine (Arg-Arg)IBA 12/2010
1	3- ((5- (6- methylpyridin- 2- yl)- 4- (quinoxalin- 6- yl)- 1H- imidazol- 2- yl)methyl)benzamideIBA 10/2010
1	human MIRN499 microRNAIBA 10/2010
1	ThymineIBA 10/2010
1	human MIRN149 microRNAIBA 10/2010
1	MicroRNAs (MicroRNA)IBA 10/2010
1	DNA (Deoxyribonucleic Acid)IBA 09/2010
1	Insulin-Like Growth Factor Binding ProteinsIBA 09/2010
1	Alanine (L-Alanine)FDA Link 06/2010
1	Histidine (L-Histidine)FDA Link 06/2010
1	Glycine (Aminoacetic Acid)FDA LinkGeneric 06/2010
1	Arginine (L-Arginine)FDA Link 06/2010
1	Amino Acids FDA Link 06/2010
1	Alcohol Dehydrogenase (Alcohol Dehydrogenase (NAD+))IBA 06/2010
1	Non-Receptor Type 13 Protein Tyrosine PhosphataseIBA 12/2009
1	Transforming Growth Factor beta1 (TGF beta 1)IBA 10/2009
1	CytokinesIBA 05/2009
1	InterleukinsIBA 05/2009
1	Small Interfering RNA (siRNA)IBA 05/2009
1	Laminin (Merosin)IBA 06/2005
1	Transcription Factor AP-1 (Transcription Factor AP 1)IBA 09/2004
1	Superoxides (Superoxide)IBA 06/2004
1	Urokinase-Type Plasminogen Activator (Urokinase)FDA Link 04/2004
1	I-kappa B Proteins (I kappa B)IBA 03/2003
1	Antineoplastic Agents (Antineoplastics)IBA 03/2003

Therapy/Procedure

9	Drug Therapy (Chemotherapy) 10/2019 - 11/2013
6	Therapeutics 01/2021 - 09/2014
3	Adjuvant Chemotherapy 01/2018 - 11/2016
2	Chest Tubes (Chest Tube) 01/2020 - 02/2014
2	Radiotherapy 10/2017 - 07/2013
1	Mastectomy (Mammectomy) 01/2021
1	Segmental Mastectomy (Lumpectomy) 01/2021
1	Patient Readmission 01/2020
1	Minimally Invasive Surgical Procedures 01/2020
1	Colectomy 01/2018
1	Lymph Node Excision (Lymph Node Dissection) 01/2018
1	Pleurodesis 01/2018
1	Catheters 01/2018
1	Aftercare (After-Treatment) 10/2017
1	Thoracotomy 02/2014